Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Zenicor Medical Systems AB's Net Margin % or its related term are showing as below:
XSAT:ZENI'
s Net Margin % Range Over the Past 10 Years
Min: -23.13 Med: -8.29 Max: 7.95
Current: 2.88
XSAT:ZENI's Net Margin % is ranked better than 51.84% of 816
companies
in the Medical Devices & Instruments industry
Industry Median: 2.11
vs XSAT:ZENI: 2.88
Zenicor Medical Systems AB (XSAT:ZENI) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Zenicor Medical Systems AB Net Margin % Related Terms
Zenicor Medical Systems AB Net Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSAT:ZENI vs ABT, SYK, MDT: Net Margin % Comparison
For the Medical Devices subindustry, Zenicor Medical Systems AB's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zenicor Medical Systems AB Net Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Zenicor Medical Systems AB's Net Margin % distribution charts can be found below:
* The bar in red indicates where Zenicor Medical Systems AB's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zenicor Medical Systems AB (XSAT:ZENI) has a Net Margin % of 2.13% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Zenicor Medical Systems AB and its competitors. According to the industry distribution chart, Zenicor Medical Systems AB ranks #393 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 48.2%.
Is Zenicor Medical Systems AB's Net Margin % too high?
Zenicor Medical Systems AB's current Net Margin % is 2.13%. The Medical Devices & Instruments industry median Net Margin % is 2.11. Zenicor Medical Systems AB's value of 2.13% is 0.9% above this industry median. Based on the distribution chart, Zenicor Medical Systems AB ranks #393 out of 816 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Zenicor Medical Systems AB has a GF Score™ of 50/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Zenicor Medical Systems AB's Net Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Zenicor Medical Systems AB ranks #393 out of 816 companies for Net Margin %. This puts Zenicor Medical Systems AB in the upper half of its industry. The industry median Net Margin % is 2.11. Zenicor Medical Systems AB's value of 2.13% is 0.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Devices & Instruments company?
The median Net Margin % among Medical Devices & Instruments companies is 2.11, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zenicor Medical Systems AB's current Net Margin % of 2.13% is 0.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Zenicor Medical Systems AB and its competitors. For the Medical Devices & Instruments industry, the median Net Margin % is 2.11 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zenicor Medical Systems AB's current Net Margin % is 2.13%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zenicor Medical Systems AB stock overvalued right now?
Based on GuruFocus' analysis, Zenicor Medical Systems AB (XSAT:ZENI) is currently considered Modestly Undervalued. The stock's GF Value™ is kr1.32, compared to a current price of kr0.95 — trading 28% below its estimated fair value. The current Net Margin % is 2.13% and 0.9% above the Medical Devices & Instruments industry median of 2.11. Zenicor Medical Systems AB's overall GF Score™ is 50/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Zenicor Medical Systems AB (XSAT:ZENI), the current Net Margin % is 2.13% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zenicor Medical Systems AB (XSAT:ZENI) Overvalued in 2026?
Based on GuruFocus' analysis, Zenicor Medical Systems AB stock appears to be undervalued.
The current stock price of kr0.95 is trading 28% below its estimated GF Value™ of kr1.32.
GuruFocus considers Zenicor Medical Systems AB to be Modestly Undervalued.
Key valuation signals for XSAT:ZENI:
Net Margin %: 2.13%
GF Value™: kr1.32 vs. price of kr0.95 (28% below fair value)
Industry Position: 0.9% above the Medical Devices & Instruments median (#393 of 816)
No single metric tells the full story. See the XSAT:ZENI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSAT:ZENI has been successfully added to your 
